anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) Antibodies

Members of the CEACAM subfamily, including CEACAM5, belong to the CEA gene family. Additionally we are shipping CEACAM5 Kits (10) and CEACAM5 Proteins (10) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
CEACAM5 292701  
CEACAM5 1048 P06731
CEACAM5 73250 Q3UKK2
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-CEACAM5 Antibodies at antibodies-online.com

Showing 10 out of 465 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Mouse Un-conjugated IHC (p), WB 0.1 mg Log in to see 6 to 8 Days
$313.50
Details
Human Rabbit Un-conjugated EIA, WB 0.4 mL Log in to see 6 to 8 Days
$390.50
Details
Human Rabbit Un-conjugated FACS, IHC (p), WB Western blot analysis of CEACAM antibody (N-term) (ABIN391544) in HepG2 cell line lysates (35 µg/lane). CEACAM (arrow) was detected using the purified polyclonal antibody. Formalin-fixed and paraffin-embedded human hepatocarcinoma with CEACAM Antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. 400 μL Log in to see 10 to 11 Days
$324.50
Details
Human Rabbit Un-conjugated IHC (fro), IHC (p) Formalin fixed paraffin embedded human colon carcinoma stained with CEA antibody. ABIN115284 0.5 mL Log in to see 6 to 8 Days
$253.00
Details
Human Mouse Un-conjugated IHC (fro), IHC (p)   0.2 mg Log in to see 6 to 8 Days
$445.50
Details
Human Mouse Un-conjugated ELISA, IF (p), IHC (p), WB Human CEA lysates probed with Mouse Anti-CEA (B5) Monoclonal Antibody, Unconjugated (bsm-1624M) at 1:300 overnight at 4˚C. Followed by a conjugated secondary antibody  at 1:5000 for 90 min at 37˚C. 100 μL Log in to see 3 to 7 Days
$307.45
Details
Human Mouse Un-conjugated EIA, FACS, IHC (fro), IHC (p)   0.2 mg Log in to see 6 to 8 Days
$467.50
Details
Human Mouse FITC FACS   25 μg Log in to see 6 to 8 Days
$198.00
Details
Human Rabbit Un-conjugated IHC (p), ELISA, WB Anti-human CEACAM5 antibody, Western blotting Lane 1: Recombinant Human CEA Protein 5ng Lane 2: Recombinant Human CEA Protein 2 100 μg Log in to see 4 to 6 Days
$240.00
Details
Human Mouse Un-conjugated cELISA, FACS, IHC (fro), ELISA, WB Specificity testing of 26/3/13. Members of the CEA family were expressed on BOSC cells after transient transfection with expression vectors containing either the cDNA of CEACAM1, 5, 6, 7 or 8. Recognition of CEACAM3, 4 and of a recombinant transmembrane- FACS analysis of BOSC23 cells using 26/3/13. BOSC23 cells were transiently transfected with an expres-sion vector encoding either CEACAM5 (red curve) or an irrelevant protein (control transfectant). Binding of 26/3/13 was detected witha PE conjugated sec 100 μg Log in to see 6 to 7 Days
$386.93
Details

CEACAM5 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Rat (Rattus) ,


Human , , , ,
, , ,
,
, , , , , , , , , , , , , , , , , , ,
Mouse (Murine) ,


Top referenced anti-CEACAM5 Antibodies

  1. Human Monoclonal CEACAM5 Primary Antibody for cELISA, FACS - ABIN108727 : Baczy?ska, Wietrzyk, Madej, Krop-Watorek, Dabrowska, Widerak, Opolski, Ugorski: The tumorigenic potential of human CX-1 colon adenocarcinoma cells depends on carcinoembryonic antigen (CEACAM5) expression. in Cellular & molecular biology letters 2003 (PubMed)
    Show all 14 references for 108727

  2. Human Monoclonal CEACAM5 Primary Antibody for ELISA, IF (p) - ABIN722946 : Yu, Zhan, Liu, Lv, Duan: Plasma-enhanced antibody immobilization for the development of a capillary-based carcinoembryonic antigen immunosensor using laser-induced fluorescence spectroscopy. in Analytical chemistry 2013 (PubMed)
    Show all 8 references for 722946

  3. Human Monoclonal CEACAM5 Primary Antibody for IHC (p), WB - ABIN1106531 : GOLD, FREEDMAN: DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. in The Journal of experimental medicine 1970 (PubMed)
    Show all 2 references for 1106531

  4. Human Polyclonal CEACAM5 Primary Antibody for IHC (fro), IHC (p) - ABIN115285 : Nap, Keuning, Burtin, Oosterhuis, Fleuren: CEA and NCA in benign and malignant breast tumors. in American journal of clinical pathology 1984 (PubMed)
    Show all 2 references for 115285

  5. Human Monoclonal CEACAM5 Primary Antibody for FACS - ABIN319988 : Price: Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies. in British journal of cancer 1988 (PubMed)
    Show all 2 references for 319988

  6. Human Polyclonal CEACAM5 Primary Antibody for EIA, WB - ABIN452835 : Lagoudianakis, Kataki, Manouras, Memos, Papadima, Derventzi, Zografos, Papadopoulos, Katergiannakis, Konstadoulakis: Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system. in The Journal of surgical research 2009 (PubMed)
    Show all 2 references for 452835

  7. Human Polyclonal CEACAM5 Primary Antibody for FACS, IHC (p) - ABIN391544 : Gambichler, Grothe, Rotterdam, Altmeyer, Kreuter: Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions. in American journal of clinical pathology 2009 (PubMed)

More Antibodies against CEACAM5 Interaction Partners

Human Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) interaction partners

  1. Combination of the two tumor markers, CEA and CYFRA21-1, is a predictive and prognostic marker of docetaxel monotherapy for previously treated NSCLC patients

  2. Patients with CEA-High stage I NSCLC have a higher risk of regional or systemic relapse and should be followed-up carefully.

  3. Postoperative CEA level >2.5 ng/ml is a predictor of distant metastasis and a negative prognostic factor for survival in rectal cancer patients who receive preoperative chemoradiotherapy and curative surgery.

  4. Data show that triple-negative breast cancer (TNBC) patients with pre-therapeutic serum high levels of both carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) had shorter overall survival (OS) and disease-free survival (DFS (show FST Antibodies)) rates than those in the low-level groups.

  5. Serum CEA level is not influenced by the presence of benign dominant biliary stricture or superimposed bacterial cholangitis in patients with primary sclerosing cholangitis.

  6. Preoperative-CEA was elevated (>/=5.0 ng/mL) in 73.6% of the colorectal cancer patients and remained elevated after surgery in 32.7% of the patients. Elevated postoperative-CA 19-9 (>/=50 U/mL) was observed in 9.5% of the patients. Neither elevated pre-CEA nor elevated pre-CA 19-9 was associated with relapse-free survival (RFS) but both elevated post-CEA and elevated post-CA 19-9 were associated with reduced RFS.

  7. the diagnostic sensitivity and specificity of serum reactive oxygen species modulator 1 (show ROMO1 Antibodies) were only 41.38% and 86.21%, respectively, with the cutoff value of 27.22 ng/mL. The sensitivity and specificity of pleural fluid carcinoembryonic antigen were 69.23% and 88.00%, respectively, at the cutoff value of 3.05 ng/mL, while serum carcinoembryonic antigen were 80.77% and 72.00% at the cutoff value of 2.60 ng/mL.

  8. we demonstrate that the incorporation of a 2A self-processing peptide derived from foot-and-mouth disease virus conveying co-translational cleavage into a two-chain anti-CD3 (show CD3 Antibodies) x anti-CEA diabody gene enables near-equimolar expression of diabody chains 1 and 2, and thus increases the final amount of assembled diabody.

  9. Taken together, the results of our study identified CEACAM5 as a novel cell surface binding target of Middle East respiratory syndrome coronavirus that facilitates infection by augmenting the attachment of the virus to the host cell surface.

  10. Data show that carcinoembryonic antigen (CEA) modestly differentiated between mucinous and nonmucinous lesions, and amylase (show AMY Antibodies) did not distinguish intraductal papillary mucinous neoplasms (IPMNs) from mucinous cystadenomas (MCAs).

Mouse (Murine) Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5) interaction partners

  1. a new mechanistic insight into how the CEA (show CEA Antibodies) IgV-like N domain participates in cellular events that can have a macroscopic impact in terms of cancer progression and metastasis.

CEACAM5 Antigen Profile

Protein Summary

Members of the CEACAM subfamily, including CEACAM5, belong to the CEA gene family. For general information on the CEA gene family, see CEACAM1 (MIM 109770).

Gene names and symbols associated with CEACAM5

  • carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) antibody
  • carcinoembryonic antigen (CEACAM5) antibody
  • carcinoembryonic antigen-related cell adhesion molecule 20 (Ceacam20) antibody
  • carcinoembryonic antigen-related cell adhesion molecule 5 (Ceacam5) antibody
  • 1600029H12Rik antibody
  • CD66e antibody
  • CEA antibody
  • CEACAM antibody
  • CEACAM5 antibody
  • Psg30 antibody
  • RGD1311281 antibody

Protein level used designations for CEACAM5

carcinoembryonic antigen-related cell adhesion molecule 5 , carcinoembryonic antigen , carcinoembryonic antigen-related cell adhesion molecule 5-like , CEA-related cell adhesion molecule 20 , meconium antigen 100 , pregnancy-specific glycoprotein 30

GENE ID SPECIES
705689 Macaca mulatta
100409241 Callithrix jacchus
100435374 Pongo abelii
456062 Pan troglodytes
100606339 Nomascus leucogenys
282174 Bos taurus
292701 Rattus norvegicus
1048 Homo sapiens
73250 Mus musculus
Selected quality suppliers for anti-CEACAM5 (CEACAM5) Antibodies
Did you look for something else?